Ovarian  	Ovarian  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
:  	:  	 :	O
markers  	markers  	 NN	O
of  	of  	 IN	O
response  	response  	 NN	O
Despite  	Despite  	 IN	O
improved  	improved  	 JJ	O
knowledge  	knowledge  	 NN	O
regarding  	regarding  	 VBG	O
the  	the  	 DT	O
etiology  	etiology  	 NN	O
of  	of  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
application  	application  	 NN	O
of  	of  	 IN	O
aggressive  	aggressive  	 JJ	B-NP
surgery  	surgery  	 NN	I-NP
and  	and  	 CC	O
chemotherapy 	chemotherapy 	 NN	O
,  	,  	 ,	O
there  	there  	 EX	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
only  	only  	 RB	O
a  	a  	 DT	O
modest  	modest  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
mortality  	mortality  	 NN	B-NP
statistics  	statistics  	 NNS	I-NP
over  	over  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
30  	30  	 CD	O
years 	years 	 NNS	O
.  	.  	 .	O
Given  	Given  	 VBN	O
these  	these  	 DT	O
results  	results  	 NNS	O
and  	and  	 CC	O
the  	the  	 DT	O
evolution  	evolution  	 NN	B-NP
of  	of  	 IN	O
targeted  	targeted  	 JJ	O
therapies 	therapies 	 NNS	O
,  	,  	 ,	O
there  	there  	 EX	O
is  	is  	 VBZ	O
an  	an  	 DT	O
increasing  	increasing  	 JJ	O
need  	need  	 NN	O
for  	for  	 IN	O
prognostic  	prognostic  	 NN	O
and  	and  	 CC	O
predictive  	predictive  	 JJ	B-NP
factors  	factors  	 NNS	I-NP
to  	to  	 TO	O
stratify  	stratify  	 VB	O
patients  	patients  	 NNS	O
for  	for  	 IN	O
individualized  	individualized  	 JJ	O
care 	care 	 NN	O
.  	.  	 .	O
Many  	Many  	 JJ	O
laboratories  	laboratories  	 NNS	O
have  	have  	 VBP	O
also  	also  	 RB	O
investigated  	investigated  	 VBD	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
individual  	individual  	 JJ	B-NP
biomarkers  	biomarkers  	 NNS	I-NP
correlating  	correlating  	 VBP	O
them  	them  	 PRP	O
with  	with  	 IN	O
clinicopathologic  	clinicopathologic  	 JJ	B-NP
characteristics 	characteristics 	 NNS	I-NP
.  	.  	 .	O
Unfortunately 	Unfortunately 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
vast  	vast  	 JJ	O
majorities  	majorities  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
biomarkers  	biomarkers  	 NNS	B-NP
have  	have  	 VBP	O
not  	not  	 RB	O
proved  	proved  	 VBN	O
clinically  	clinically  	 RB	O
valuable 	valuable 	 JJ	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
article 	article 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
review  	review  	 VBP	O
published  	published  	 VBN	O
genomic  	genomic  	 JJ	B-NP
signatures  	signatures  	 NNS	I-NP
including  	including  	 VBG	I-NP
data  	data  	 NNS	I-NP
generated  	generated  	 VBN	O
in  	in  	 IN	O
our  	our  	 PRP$	O
laboratory  	laboratory  	 NN	O
for  	for  	 IN	O
their  	their  	 PRP$	O
relevance 	relevance 	 NN	O
.  	.  	 .	O
Multiple  	Multiple  	 JJ	B-NP
published  	published  	 JJ	I-NP
expression  	expression  	 NN	I-NP
profiling  	profiling  	 NN	I-NP
articles  	articles  	 NNS	I-NP
were  	were  	 VBD	O
selected  	selected  	 VBN	O
for  	for  	 IN	O
review  	review  	 NN	O
and  	and  	 CC	O
discussion 	discussion 	 NN	O
.  	.  	 .	O
Genomic  	Genomic  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
were  	were  	 VBD	O
separated  	separated  	 VBN	O
from  	from  	 IN	O
those  	those  	 DT	O
with  	with  	 IN	O
dichotomized  	dichotomized  	 JJ	B-NP
survival  	survival  	 NN	I-NP
data  	data  	 NNS	I-NP
and  	and  	 CC	O
unsupervised  	unsupervised  	 JJ	O
analysis  	analysis  	 NN	O
to  	to  	 TO	O
identify  	identify  	 VB	O
discreet  	discreet  	 JJ	O
subsets  	subsets  	 NN	B-NP
of  	of  	 IN	O
tumors  	tumors  	 NNS	O
and  	and  	 CC	O
studies  	studies  	 NNS	O
that  	that  	 WDT	O
generated  	generated  	 VBD	O
activated  	activated  	 VBN	B-NP
pathways 	pathways 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
identification  	identification  	 NN	B-NP
of  	of  	 IN	O
prognostic  	prognostic  	 NN	O
and  	and  	 CC	O
predictive  	predictive  	 JJ	B-NP
individual  	individual  	 JJ	I-NP
biomarkers  	biomarkers  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
common 	common 	 JJ	O
.  	.  	 .	O
Few  	Few  	 JJ	O
of  	of  	 IN	O
these  	these  	 DT	O
have  	have  	 VBP	O
been  	been  	 VBN	O
validated 	validated 	 NN	O
.  	.  	 .	O
Genomic  	Genomic  	 JJ	B-NP
profiles  	profiles  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
obtained  	obtained  	 VBN	O
that  	that  	 IN	O
distinguish  	distinguish  	 JJ	O
short-  	short-  	 NN	B-NP
from  	from  	 IN	I-NP
long-term  	long-term  	 JJ	O
survivors 	survivors 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
relevance  	relevance  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
studies  	studies  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
large  	large  	 JJ	O
number  	number  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
within  	within  	 IN	O
the  	the  	 DT	O
extremes  	extremes  	 NN	O
remains  	remains  	 VBZ	O
unclear 	unclear 	 JJ	O
.  	.  	 .	O
Unsupervised  	Unsupervised  	 JJ	B-NP
clustering  	clustering  	 JJ	I-NP
studies  	studies  	 NNS	I-NP
of  	of  	 IN	I-NP
ovarian  	ovarian  	 JJ	I-NP
cancers  	cancers  	 NNS	I-NP
have  	have  	 VBP	O
identified  	identified  	 VBN	O
potential  	potential  	 JJ	B-NP
subsets  	subsets  	 NN	I-NP
of  	of  	 IN	O
tumors  	tumors  	 NNS	O
that  	that  	 WDT	O
reflect  	reflect  	 VBP	O
different  	different  	 JJ	O
clinical  	clinical  	 JJ	B-NP
behavior 	behavior 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
studies  	studies  	 NNS	O
will  	will  	 MD	O
require  	require  	 VB	O
large  	large  	 JJ	O
numbers  	numbers  	 NNS	O
of  	of  	 IN	O
independent  	independent  	 JJ	O
samples  	samples  	 NNS	O
for  	for  	 IN	O
validation 	validation 	 NN	B-NP
.  	.  	 .	O
Another  	Another  	 DT	O
approach  	approach  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
to  	to  	 TO	O
identify  	identify  	 VB	O
genes  	genes  	 NNS	O
that  	that  	 IN	O
correlate  	correlate  	 NN	O
with  	with  	 IN	O
patient  	patient  	 JJ	O
survival  	survival  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
continuous  	continuous  	 JJ	B-NP
variable 	variable 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
genes  	genes  	 NNS	O
are  	are  	 VBP	O
then  	then  	 RB	O
placed  	placed  	 VBN	O
into  	into  	 IN	O
biologic  	biologic  	 JJ	B-NP
context  	context  	 NN	I-NP
using  	using  	 VBG	O
pathway  	pathway  	 JJ	B-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
pathways  	pathways  	 NNS	O
provide  	provide  	 VBP	O
potential  	potential  	 JJ	B-NP
therapeutic  	therapeutic  	 JJ	I-NP
targets 	targets 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
those  	those  	 DT	O
patients  	patients  	 NNS	O
whose  	whose  	 WP$	O
tumors  	tumors  	 NNS	O
express  	express  	 VBP	O
these  	these  	 DT	O
targets  	targets  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
most  	most  	 RBS	O
effectively  	effectively  	 RB	O
treated  	treated  	 VBN	O
by  	by  	 IN	O
using  	using  	 VBG	O
inhibitors  	inhibitors  	 JJ	O
specific  	specific  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
pathway 	pathway 	 NN	O
.  	.  	 .	O
There  	There  	 EX	O
is  	is  	 VBZ	O
a  	a  	 DT	O
major  	major  	 JJ	O
need  	need  	 NN	O
for  	for  	 IN	O
prognostic  	prognostic  	 NN	O
and  	and  	 CC	O
predictive  	predictive  	 JJ	B-NP
biomarkers  	biomarkers  	 NN	I-NP
for  	for  	 IN	I-NP
ovarian  	ovarian  	 JJ	I-NP
cancer 	cancer 	 NN	I-NP
.  	.  	 .	O
With  	With  	 IN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
new  	new  	 JJ	O
genomic  	genomic  	 JJ	B-NP
technologies 	technologies 	 NNS	I-NP
,  	,  	 ,	O
there  	there  	 EX	O
is  	is  	 VBZ	O
an  	an  	 DT	O
opportunity  	opportunity  	 NN	O
to  	to  	 TO	O
identify  	identify  	 VB	O
gene  	gene  	 NN	B-NP
expression  	expression  	 NN	I-NP
signatures  	signatures  	 NNS	I-NP
that  	that  	 WDT	O
can  	can  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
stratify  	stratify  	 VB	O
patients  	patients  	 NNS	O
according  	according  	 VBG	O
to  	to  	 TO	O
their  	their  	 PRP$	O
ultimate  	ultimate  	 JJ	O
survival  	survival  	 NN	O
and  	and  	 CC	O
response  	response  	 NN	O
to  	to  	 TO	O
chemotherapy 	chemotherapy 	 VB	O
.  	.  	 .	O
Large  	Large  	 JJ	B-NP
independent  	independent  	 JJ	I-NP
sets  	sets  	 NNS	I-NP
and  	and  	 CC	O
robust  	robust  	 JJ	O
statistical  	statistical  	 JJ	B-NP
techniques  	techniques  	 NNS	I-NP
will  	will  	 MD	O
be  	be  	 VB	O
required  	required  	 VBN	O
to  	to  	 TO	O
fully  	fully  	 RB	O
exploit  	exploit  	 VB	O
this  	this  	 DT	O
approach 	approach 	 NN	O
.  	.  	 .	O
